UPDATE : Friday, September 20, 2019
상단여백
Biotech startups seek IPO via ‘growth potential exception’ policy
An increasing number of biotech companies are eyeing on the Korea Exchange’...
by Jeong Sae-im  |  2019-09-17 11:26
라인
Top court rejects financial regulator’s retry to discipline Samsung BioLogics
The Financial Services Commission (FSC)'s disciplinary action against S...
by Jeong Sae-im  |  2019-09-10 14:36
라인
Canada OKs Celltrion's biosimilar
Celltrion said that Health Canada has given the go-ahead for Herzuma (Ingre...
by Lee Han-soo  |  2019-09-10 12:48
라인
Samsung Bioepis launches Enbrel biosimilar in Brazil
Samsung Bioepis said that it has received sales approval for Brenzys, an En...
by Lee Han-soo  |  2019-09-10 12:21
라인
Invossa victims furious at government, Kolon for ‘doing nothing’
“We’ve never heard when and how they would do a long-term follow-up. Kolon ...
by Jeong Sae-im  |  2019-09-09 15:47
라인
Nobel laureate Honjo anticipates best combo in immunotherapies
Professor Tasuku Honjo of Kyoto University said he was expecting a good out...
by Jeong Sae-im  |  2019-09-06 16:29
라인
Change in licensing-out contract may be bad sign for Intron Biotechnology
Intron Biotechnology said the conditions for last November’s deal with a mu...
by Jeong Sae-im  |  2019-08-30 14:47
라인
Huons, Prestige Bio to develop biosimilars
Huons said that it plans to enter the biosimilar market by collaborating wi...
by Lee Han-soo  |  2019-08-28 16:05
라인
New way found to heal wounds of autoimmune disease patients
Korean researchers have found a new method to quickly heal the wounds of pa...
by Song Soo-youn  |  2019-08-28 15:19
라인
‘GI Innovation will be small but strong leader of bioindustry’
“GI Innovation, armed with both basic science and development strategy, wil...
by Kim Yun-mi  |  2019-08-27 15:57
라인
Invossa victims, Kolon shareholders demand apology, compensation
After the Korea Exchange’s Corporate Review Committee decided to delist Kol...
by Jeong Sae-im  |  2019-08-27 15:40
라인
Regulator decides to delist Kolon TissueGene
Kolon TissueGene, an affiliate of Kolon Life Science, is on the verge of be...
by Jeong Sae-im  |  2019-08-27 12:15
라인
Medipost’s Pneumostem gets FDA’s fast-track designation
Medipost said that the U.S. Food and Drug Administration has given a fast- ...
by Lee Han-soo  |  2019-08-23 17:51
라인
GenNBio to test transplanting pig’s pancreatic islet into human next year
GenNBio said it would officially enter the market of transplanting organs f...
by Jeong Sae-im  |  2019-08-23 13:53
라인
Japan gives further nod to Celltrion's breast cancer biosimilar
Celltrion Healthcare said that Japan's Ministry of Health, Labour and W...
by Lee Han-soo  |  2019-08-22 16:47
라인
Pharmicell submits new drug application for ovarian cancer treatment
Pharmicell said that it has filed an investigational new drug application t...
by Lee Han-soo  |  2019-08-19 13:10
라인
Stock exchange names Kolon Life Science as administrative issue
Kolon Life Science, once one of the most promising bio-stocks, has been dow...
by Lee Han-soo  |  2019-08-16 16:49
라인
Medipost’s stem cell therapy, cord blood bank show solid growth
Medipost’s stem cell therapy Cartistem for osteoarthritis and umbilical cor...
by Jeong Sae-im  |  2019-08-16 16:18
라인
CHA Biotech wins patent for placenta-derived mesenchymal stem cells
CHA Biotech said that it has obtained a patent for the use of placenta-deri...
by Lee Han-soo  |  2019-08-12 18:24
라인
Samsung BioLogics implants cell-culturing tech
Samsung BioLogics said that it has implanted a new cell-culturing technolog...
by Lee Han-soo  |  2019-08-12 16:05
여백
여백
여백
Back to Top